No Data
No Data
Galapagos NV Earnings Call: Expansion Amid Financial Challenges
Galapagos NV Announces Key Resolutions From Annual Shareholders' Meeting
Morgan Stanley Maintains Galapagos(GLPG.US) With Sell Rating, Maintains Target Price $22
Galapagos First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Analysts Conflicted on These Healthcare Names: Centene (CNC), Merck & Company (MRK) and Galapagos (GLPG)
Express News | Galapagos NV : RBC Cuts Target Price to $27 From $32
Jazdgr8 : roll roll
勇敢M00M00_不怕翻车 : do invite me if you are throwing a party full of hot models![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
Coach Donnie : Congratulations




盘丝大仙 : Wishing you prosperity.
74950747 : ltry sounds like you should be in